NCT04828265View on ClinicalTrials.gov

Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

July 6, 2021

Study Completion Date

July 6, 2021

Conditions
Healthy Male
Interventions
BIOLOGICAL

Aldafermin

Single dose of aldafermin

Trial Locations (1)

90630

NGM Clinical Study Site 112, Cypress

Sponsors
All Listed Sponsors
lead

NGM Biopharmaceuticals, Inc

INDUSTRY